Recently, AGTR1 has drawn considerable interest, not only in the field of cardiovascular risk but also in several types of gynecological malignancies, such as endometrial cancer[5,6], cervical carcinoma[7], and especially ovarian cancer[8-10]. Here, AGTR1 is linked to ovarian carcinoma.